Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 23 Jun 2026 for Schrodinger, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
2
T+90 hit rate
67%
T+90 mean return
-6.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jeffrey Chodakewitz: trading record in brief
This profile gathers the share dealings of Jeffrey Chodakewitz across 4 companies, led by Schrodinger, Inc., Adicet Bio, Inc. and Vertex Pharmaceuticals INC / MA. In total, 11 filings cover trades dated from 2 February 2016 to 22 June 2026.
On the market, this insider has only sold: 2 sales. The amount is not disclosed for 2 filings. Other entries cover 9 share grants.
The record was last updated on 23 June 2026 with a share grant in Schrodinger, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey Chodakewitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
8,141 sharesCommon StockSEC:0001610876-26-000003:0
1,371 sharesCommon StockSEC:0001689548-26-000063:0
5,997 shares0Common StockSEC:0001490978-25-000092:0
5,900 shares0Common StockSEC:0000950170-25-086163:0
5,000 shares0Common StockSEC:0001490978-24-000062:0
5,900 shares0Common StockSEC:0000950170-24-070613:0
6,250 shares0Common StockSEC:0001490978-23-000080:0
5,900 shares0Common StockSEC:0001209191-23-033961:0
14,416 sharesCommon StockSEC:0001209191-16-095841:0
1,100 sharesCommon StockSEC:0001209191-16-095841:1
1,275 sharesCommon StockSEC:0001209191-16-095841:2
11 of 11 declarations
